Tidal Investments LLC Acquires 46,215 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Tidal Investments LLC raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 1,422.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 49,465 shares of the biotechnology company's stock after buying an additional 46,215 shares during the quarter. Tidal Investments LLC owned about 0.06% of Axon Enterprise worth $29,398,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Toronto Dominion Bank boosted its holdings in Axon Enterprise by 38.3% in the fourth quarter. Toronto Dominion Bank now owns 33,273 shares of the biotechnology company's stock valued at $19,775,000 after acquiring an additional 9,209 shares in the last quarter. Scientech Research LLC lifted its position in shares of Axon Enterprise by 152.6% in the 4th quarter. Scientech Research LLC now owns 2,006 shares of the biotechnology company's stock worth $1,192,000 after purchasing an additional 1,212 shares during the period. Siemens Fonds Invest GmbH boosted its stake in shares of Axon Enterprise by 219.7% during the 4th quarter. Siemens Fonds Invest GmbH now owns 2,481 shares of the biotechnology company's stock valued at $1,475,000 after purchasing an additional 1,705 shares in the last quarter. Skye Global Management LP bought a new stake in shares of Axon Enterprise during the 4th quarter valued at about $1,902,000. Finally, Shell Asset Management Co. increased its position in shares of Axon Enterprise by 7.5% during the fourth quarter. Shell Asset Management Co. now owns 2,449 shares of the biotechnology company's stock valued at $1,455,000 after buying an additional 170 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Brittany Bagley sold 3,400 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total value of $2,380,000.00. Following the completion of the transaction, the chief financial officer now owns 131,833 shares in the company, valued at approximately $92,283,100. This trade represents a 2.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 25,064 shares of company stock valued at $15,817,127 in the last 90 days. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Stock Up 0.1%

AXON stock traded up $0.43 during midday trading on Tuesday, hitting $742.75. The company's stock had a trading volume of 383,468 shares, compared to its average volume of 751,632. The firm's 50-day moving average is $592.46 and its 200-day moving average is $598.92. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $744.51. The company has a market cap of $57.82 billion, a PE ratio of 191.93, a P/E/G ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same period in the prior year, the company posted $1.15 earnings per share. The company's quarterly revenue was up 31.3% on a year-over-year basis. On average, equities research analysts forecast that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on AXON. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Barclays upped their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. The Goldman Sachs Group raised their price objective on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Finally, Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus price target of $652.73.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.